Dolby Laboratories Future Growth
Future criteria checks 1/6
Dolby Laboratories is forecast to grow earnings and revenue by 10.5% and 5.2% per annum respectively while EPS is expected to grow by 8.6% per annum.
Key information
10.5%
Earnings growth rate
8.6%
EPS growth rate
Software earnings growth | 16.9% |
Revenue growth rate | 5.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 30 Jan 2025 |
Recent future growth updates
Recent updates
Are Investors Undervaluing Dolby Laboratories, Inc. (NYSE:DLB) By 38%?
Jan 26Should You Investigate Dolby Laboratories, Inc. (NYSE:DLB) At US$78.28?
Dec 26Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Not Quite Adding Up
Dec 10Dolby Laboratories: Picture Improved, But Still A Bit Too Expensive
Nov 22Dolby Laboratories (NYSE:DLB) Hasn't Managed To Accelerate Its Returns
Oct 28Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Sep 22Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital
Aug 22Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion
Aug 13We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)
Jul 26Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
Jun 10Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?
Jun 07Dolby Laboratories Remains A Hold
May 14Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 05Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors
May 02Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13Dolby Laboratories Sees Return To Growth Ahead
Jun 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2027 | 1,524 | 338 | 533 | 561 | 1 |
9/30/2026 | 1,430 | 285 | 480 | 508 | 3 |
9/30/2025 | 1,356 | 245 | 421 | 449 | 3 |
12/27/2024 | 1,315 | 263 | 395 | 426 | N/A |
9/27/2024 | 1,274 | 262 | 297 | 327 | N/A |
6/28/2024 | 1,259 | 212 | 265 | 296 | N/A |
3/29/2024 | 1,269 | 190 | 365 | 396 | N/A |
12/29/2023 | 1,280 | 188 | 290 | 319 | N/A |
9/29/2023 | 1,300 | 201 | 337 | 367 | N/A |
6/30/2023 | 1,287 | 219 | 301 | 333 | N/A |
3/31/2023 | 1,279 | 242 | 348 | 385 | N/A |
12/30/2022 | 1,237 | 183 | 303 | 343 | N/A |
9/30/2022 | 1,254 | 184 | 259 | 319 | N/A |
7/1/2022 | 1,261 | 201 | 316 | 377 | N/A |
4/1/2022 | 1,258 | 216 | 314 | 377 | N/A |
12/31/2021 | 1,243 | 255 | 332 | 397 | N/A |
9/24/2021 | 1,281 | 310 | 393 | 448 | N/A |
6/25/2021 | 1,267 | 293 | 398 | 451 | N/A |
3/26/2021 | 1,228 | 306 | 359 | 413 | N/A |
12/25/2020 | 1,260 | 318 | 334 | 395 | N/A |
9/25/2020 | 1,162 | 231 | 275 | 344 | N/A |
6/26/2020 | 1,189 | 248 | 287 | 362 | N/A |
3/27/2020 | 1,245 | 221 | 234 | 319 | N/A |
12/27/2019 | 1,231 | 206 | 195 | 302 | N/A |
9/27/2019 | 1,242 | 255 | 214 | 328 | N/A |
6/28/2019 | 1,183 | 238 | 194 | 309 | N/A |
3/29/2019 | 1,096 | 201 | 253 | 360 | N/A |
12/28/2018 | 1,057 | 193 | 307 | 392 | N/A |
9/28/2018 | 1,055 | 42 | N/A | 352 | N/A |
6/29/2018 | 1,056 | 37 | N/A | 321 | N/A |
3/30/2018 | 1,147 | 110 | N/A | 317 | N/A |
12/29/2017 | 1,115 | 95 | N/A | 324 | N/A |
9/29/2017 | 1,080 | 206 | N/A | 378 | N/A |
6/30/2017 | 1,072 | 204 | N/A | 370 | N/A |
3/31/2017 | 1,044 | 192 | N/A | 359 | N/A |
12/30/2016 | 1,051 | 208 | N/A | 360 | N/A |
9/30/2016 | 1,026 | 186 | N/A | 360 | N/A |
7/1/2016 | 1,025 | 208 | N/A | 367 | N/A |
4/1/2016 | 980 | 180 | N/A | 288 | N/A |
1/1/2016 | 977 | 171 | N/A | 373 | N/A |
9/25/2015 | 971 | 181 | N/A | 309 | N/A |
6/26/2015 | 965 | 181 | N/A | 316 | N/A |
3/27/2015 | 956 | 185 | N/A | 360 | N/A |
12/26/2014 | 963 | 203 | N/A | 288 | N/A |
9/26/2014 | 960 | 206 | N/A | 362 | N/A |
6/27/2014 | 950 | 206 | N/A | 339 | N/A |
3/28/2014 | 934 | 196 | N/A | 332 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DLB's forecast earnings growth (10.5% per year) is above the savings rate (2.6%).
Earnings vs Market: DLB's earnings (10.5% per year) are forecast to grow slower than the US market (15% per year).
High Growth Earnings: DLB's earnings are forecast to grow, but not significantly.
Revenue vs Market: DLB's revenue (5.2% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: DLB's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DLB's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 22:41 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/12/27 |
Annual Earnings | 2024/09/27 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dolby Laboratories, Inc. is covered by 22 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Bright | Avondale Partners |
Ishan Majumdar | Baptista Research |
Gary Prestopino | Barrington Research Associates, Inc. |